<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Evoke Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Evoke Pharma, Inc.

    Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $69,400,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Gonyer, R.Ph.
    • FOUNDED
      2007
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Pacira BioSciences, Inc.

    Pacira BioSciences, Inc.

    Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the deve...

    Pacira BioSciences, Inc. is a specialty pharmac...

    Filing Type:    PU
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    electroCore, Inc.

    electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated t...

    electroCore, Inc. is a commercial stage bioelec...

    Filing Type:    PU
    Voyager Therapeutics, Inc.

    Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debi...

    Voyager Therapeutics is developing life-changin...

    Filing Type:    PU
    Ionis Pharmaceuticals, Inc.

    Ionis Pharmaceuticals, Inc.

    Ionis is a sustainably profitable, multi-product company with a pipeline of more t...

    Ionis is a sustainably profitable, multi-produc...

    Filing Type:    PU
    Catalyst Biosciences, Inc.

    Catalyst Biosciences, Inc.

    Catalyst is focused on developing novel medicines to address serious medical condi...

    Catalyst is focused on developing novel medicin...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Novan, Inc.

    Novan, Inc.

    Novan, Inc. is a clinical development-stage biotechnology company focused on lever...

    Novan, Inc. is a clinical development-stage bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.